000 | 01205 a2200337 4500 | ||
---|---|---|---|
005 | 20250514032521.0 | ||
264 | 0 | _c20020717 | |
008 | 200207s 0 0 eng d | ||
022 | _a0028-3843 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMerims, D | |
245 | 0 | 0 |
_aThe role of glutamatergic transmission in the pathogenesis of levodopa-induced dyskinesias. Potential therapeutic approaches. _h[electronic resource] |
260 |
_bNeurologia i neurochirurgia polska _c2001 |
||
300 |
_a65-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAnticonvulsants _xtherapeutic use |
650 | 0 | 4 |
_aAntiparkinson Agents _xadverse effects |
650 | 0 | 4 |
_aDopamine Agents _xadverse effects |
650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xdrug therapy |
650 | 0 | 4 |
_aExcitatory Amino Acid Agents _xtherapeutic use |
650 | 0 | 4 |
_aGlutamic Acid _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLevodopa _xadverse effects |
650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
650 | 0 | 4 |
_aRiluzole _xtherapeutic use |
700 | 1 | _aZiv, I | |
700 | 1 | _aSherki, Y | |
700 | 1 | _aDjaldetti, R | |
700 | 1 | _aMelamed, E | |
773 | 0 |
_tNeurologia i neurochirurgia polska _gvol. 35 Suppl 3 _gp. 65-8 |
|
999 |
_c11900562 _d11900562 |